ABSTRACT It has been shown that BCAAs, especially leucine, regulate skeletal muscle protein metabolism. However, it remains unclear how BCAAs regulate muscle protein metabolism and lead to anabolism in vivo. We examined muscle protein synthesis rate and breakdown rate simultaneously during BCAA infusion in muscle atrophy models as well as in normal healthy rats. Corticosterone-treated rats and hindlimb-immobilized rats were used as muscle atrophy models. Muscle protein synthesis rate and breakdown rate were measured as phenylalanine kinetics across the hindlimb. In anesthetized normal rats, BCAAs stimulated muscle protein synthesis despite low insulin concentration and did not suppress muscle protein breakdown. In corticosterone-treated rats, BCAAs failed to restore inhibited muscle protein synthesis, but reduced muscle protein breakdown. Immobilization of hindlimb increased muscle protein breakdown within a day. BCAAs did not change muscle protein metabolism, although essential amino acids (EAAs) suppressed muscle protein breakdown in hindlimb-immobilized rats. We also evaluated changes of fractional synthesis rate (FSR) of skeletal muscle protein during infusion of leucine alone or EAAs for 4 h in anesthetized normal rats. FSR showed a transient increase at 15-30 min of leucine infusion and then declined, whereas FSR stayed elevated throughout EAA infusion. We concluded that 1) BCAAs primarily stimulate muscle protein synthesis in normal rats independently of insulin; 2) EAAs are required to maintain the BCAA stimulation of muscle protein synthesis; and 3) The effects of BCAAs on muscle protein metabolism differ between atrophy models. J. Nutr. 136: 234S-236S, 2006.
BCAAs, especially leucine, are the key amino acids to modulate muscle protein metabolism and lead to muscle protein anabolism. It is thought that leucine is a nutritional signal to indicate that amino acids are available after a meal containing protein (1) . It has been shown that BCAAs promote muscle protein synthesis and inhibit muscle protein breakdown in vitro in incubated diaphragms (2, 3) and in perfused rat hindlimb (4) . Also, it has been shown that leucine or BCAA administration stimulates muscle protein synthesis rate in rat in vivo studies (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) . Leucine-mediated signaling pathways involved in control of protein synthesis in rat skeletal muscle have been extensively studied by Jefferson's group (8) (9) (10) (11) (12) (13) (16) (17) (18) . Meanwhile, information about the effect of BCAAs on in vivo rat muscle protein breakdown is less available.
Some articles suggest that, in humans, leucine promotes muscle protein synthesis (19, 20) , but most others show suppressed muscle protein breakdown without increased protein synthesis during leucine (21) or BCAA (22,23) infusion. Matthews recently discussed this discrepancy between human and rat studies and pointed out that one of the possible reasons is the differences in physiology and signaling pathways between species (24). We think it also has to be considered that the methods (i.e., how leucine/BCAAs were given and how and when muscle protein synthesis was determined) used in those studies are different. For example, in rat studies, muscle protein synthesis rates were determined by amino acid tracer incorporation into muscle protein (5-15) (within 1 h after leucine/BCAA administration in many cases); in human studies, in contrast, arterial-venous balance methods using stable isotope tracers were used to determine muscle protein synthesis and breakdown at the end of 4 h of leucine infusion (21) by the tracer incorporation technique, was observed within 90 min after a single bolus injection of leucine (20) . Overall, it remains unclear how BCAAs regulate muscle protein metabolism and lead to anabolism in vivo, whether through stimulation of protein synthesis or inhibition of proteolysis.
Effect of BCAA on muscle protein metabolism in normal rats
Buse (6) intravenously infused BCAAs with glucose and isotope tracer into normal food-deprived rats for 6 h and observed increased tracer incorporation into muscle protein, which suggests increased muscle protein synthesis. In normal healthy rats, 1 h of intravenous infusion of BCAAs with glucose or with insulin stimulates muscle protein synthesis (7) . A leucine-supplemented meal enhances the postprandial (90-120 min after meal) muscle protein synthesis rate in adult rats as well as old rats (14) and its anabolic effect persists at least 10 d (15). However, there was no stimulation of muscle protein synthesis either within 10 min after intravenous injection of leucine alone or 1 h after intraperitoneal injection of leucine alone (25) . Oral gavage of leucine alone, however, increases the muscle protein synthesis rate 20 to 60 min after gavage in normal rats (8) (9) (10) 12, 16) . As just described, leucine/BCAA stimulation of muscle protein synthesis in rats is reported in many papers, but there is no information on muscle protein breakdown because only isotope tracer incorporation techniques were used in all these studies. Therefore, we examined muscle protein synthesis rate and breakdown rate simultaneously during BCAA infusion in normal healthy rats under ketamine-xylazine general anesthesia, which blunts insulin secretion (26,27). Muscle protein synthesis rate and breakdown rate were measured as phenylalanine kinetics across the hindlimb, determined by the three-pool model (28) Murakami, and H. Suzuki, unpublished results). Muscle protein breakdown was unchanged and negative phenylalanine net balance tended to be improved. Plasma insulin concentrations were much lower than the concentration after overnight fasting because of ketamine-xylazine anesthesia. We confirmed by an arterial-venous balance method with an isotope tracer that BCAAs primarily stimulate muscle protein synthesis in normal rats, as shown in earlier studies in which muscle protein synthesis was determined by tracer incorporation methods, and BCAA stimulation of muscle protein synthesis occurs independently of insulin in normal rats. The latter is comparable to the results of Crozier et al. (16) , who found that oral administration of leucine as low as 135 mg/kg enhanced skeletal muscle protein synthesis, whereas it did not affect serum insulin concentration.
Effect of BCAA on muscle protein metabolism in muscle atrophying rats
The catabolic effects of glucocorticoids on muscle protein metabolism are well known. Glucocorticoid administration results in muscle atrophy. It is generally agreed that glucocorticoids inhibit muscle protein synthesis and stimulate muscle protein breakdown (29) (30) (31) (32) (33) (34) . We evaluated the effects of amino acid infusion on muscle protein synthesis and breakdown by an arterial-venous balance method using stable isotope tracers in corticosterone-treated (100 mgÁkg 21 Áday 21 subcutaneously for 3 d) rats. When BCAAs (246 mgÁkg 21 Áh 21 for 2 h; prime: 164 mg/kg) were infused into corticosterone-treated rats, improved net balance and reduced muscle protein breakdown were observed at the last 20 min of the infusion (H. Kobayashi, H. Suzuki, unpublished results). BCAA stimulation of muscle protein synthesis seen in normal rats was not observed in corticosterone-treated rats. Rieu et al. (35) reported that muscles from adult and old rats treated with dexamethasone became leucine resistant to protein synthesis. It has already been shown that glucocorticoids inhibit amino acid-mediated signaling pathways involved in control of muscle protein synthesis in rats (36) as well as in humans (37, 38) .
Muscle protein metabolism in disuse-atrophy model rats was also examined. Although it has been reported that muscle protein synthesis significantly declined during the first 6 h of immobilization (39) (21) (22) (23) because leucine or BCAA was infused for 3 h or longer and muscle protein turnover rates were determined at the end of infusion.
Conclusions
Leucine primarily stimulates muscle protein synthesis in normal rats. The stimulation is transient and independent of insulin. Increased muscle protein synthesis is maintained by EAA infusion. Because different types of injury induce different protein metabolic responses (i.e., variations in synthesis versus breakdown), it is not surprising that the BCAA effect differs according to the model. Determination of the profile of protein metabolism response in a given stress situation forms the rationale for providing or not providing pharmacological amounts of BCAAs.
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